Emmanouil Saloustros, MD, D(Med)Sc Emmanouil Saloustros received his Medical Degree (MD) from the University of Thessaly in 2000. He completed his residency in Internal Medicine and subsequently his fellowship in Medical Oncology at the University Hospital of Heraklion, Crete, in 2010. He conducted postgraduate research at the Section on Endocrinology and Genetics of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH), focusing on heritable cancer predisposition syndromes, tumorigenesis, and the development of preclinical cancer models. In 2013, he was awarded a doctoral degree (D(Med)Sc) in Cancer Biology from the University of Crete School of Medicine. From 2012 to 2018, Dr. Saloustros served as Consultant in Medical Oncology at the General Hospital of Heraklion “Venizelio”, where he also established the Hereditary Cancer Clinic at the University Hospital of Heraklion. In June 2018, he joined the Faculty of Medicine of the University of Thessaly, where he is currently Associate Professor of Oncology. His research focuses on breast cancer risk assessment and management, particularly BRCA1/2-associated breast and ovarian cancers, as well as other hereditary cancer predisposition syndromes. He is also actively involved in international research on non-BRCA1/2 hereditary breast cancer through collaborations such as the Breast Cancer Association Consortium (BCAC). In addition, he has a strong interest in adolescent and young adult (AYA) oncology. Dr. Saloustros currently serves as President of the Hellenic Society of Medical Oncology (HeSMO). In this role, he is committed to advancing oncology education and training in Greece, strengthening the clinical and scientific role of medical oncology, and promoting high standards of multidisciplinary cancer care. His work also focuses on fostering academic collaboration and contributing to evidence-based health policy to improve access and quality of cancer care. He is a member of the European Society for Medical Oncology (ESMO) Faculty and participates in international research collaborations, including the Breast International Group (BIG) and the European Organisation for Research and Treatment of Cancer (EORTC).